Drug Profile
ATH 04
Alternative Names: AFFITOPE® AT04; AFFITOPE® AT04A+adjuvant; AT 04A; ATH-04; FB-6001Latest Information Update: 14 Jul 2022
Price :
$50
*
At a glance
- Originator AFFiRiS
- Class Antihyperlipidaemics; Peptide vaccines; Synthetic vaccines
- Mechanism of Action Cholesterol modulators; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Hypercholesterolaemia